YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity

por Lam, Wing, Hu, Rong, Liu, Shwu-Huey, Cheng, Peikwen, Cheng, Yung-Chi
Publicado 2023

The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906...

por Lam, Wing, Jiang, Zaoli, Guan, Fulan, Hu, Rong, Liu, Shwu-Huey, Chu, Edward, Cheng, Yung-Chi
Publicado 2014

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancem...

por Lam, Wing, Arammash, Mohammad, Cai, Wei, Guan, Fulan, Jiang, Zaoli, Liu, Shwu-Huey, Cheng, Peikwen, Cheng, Yung-Chi
Publicado 2023

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)

por Lam, Wing, Ren, Yongshen, Guan, Fulan, Jiang, Zaoli, Cheng, William, Xu, Chang-Hua, Liu, Shwu-Huey, Cheng, Yung-Chi
Publicado 2018

A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

por Changou, Chun A., Shiah, Her‐Shyong, Chen, Li‐Tzong, Liu, Servina, Luh, Frank, Liu, Shwu‐Huey, Cheng, Yung‐Chi, Yen, Yun
Publicado 2020

PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment

por Lam, Wing, Jiang, Zaoli, Guan, Fulan, Huang, Xiu, Hu, Rong, Wang, Jing, Bussom, Scott, Liu, Shwu-Huey, Zhao, Hongyu, Yen, Yun, Cheng, Yung-Chi
Publicado 2015

A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906

por Tilton, Robert, Paiva, Anthony A, Guan, Jing-Qu, Marathe, Rajendra, Jiang, Zaoli, van Eyndhoven, Winfried, Bjoraker, Jeffrey, Prusoff, Zachary, Wang, Hailong, Liu, Shwu-Huey, Cheng, Yung-Chi
Publicado 2010

Ganoderma tsugae Induces S Phase Arrest and Apoptosis in Doxorubicin-Resistant Lung Adenocarcinoma H23/0.3 Cells via Modulation of the PI3K/Akt Signaling Pathway

por Yu, Yang-Hao, Kuo, Han-Peng, Hsieh, Hui-Hsia, Li, Jhy-Wei, Hsu, Wu-Huei, Chen, Shih-Jung, Su, Muh-Hwan, Liu, Shwu-Huey, Cheng, Yung-Chi, Chen, Chih-Yi, Kao, Ming-Ching
Publicado 2012

YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment

por Yang, Xiaochen, Lam, Wing, Jiang, Zaoli, Guan, Fulan, Han, Xue, Hu, Rong, Cai, Wei, Cheng, William, Liu, Shwu-Huey, Cheng, Peikwen, Cai, Yuping, Rattray, Nicholas J. W., Johnson, Caroline H., Chen, Lieping, Cheng, Yung-Chi
Publicado 2021